Abstract
Patients with carcinoma of the cervix (31) and of the vulva (2) were treated with high doses of Methotrexate. The objective response rate was 17% with a median duration of 3 months. Three toxic deaths occurred. The response rate of high dose methotrexate in advanced and prior treated cervix cancer does not differ from that reported in prior studies with conventional doses of intravenous methotrexate. Cancer 43:459–464, 1979. Copyright © 1979 American Cancer Society
Cite
CITATION STYLE
Hakes, T., Nikrui, M., Magill, G., & Ochoa, M. (1979). Cervix cancer. Treatment with combination vincristine and high doses of methotrexate. Cancer, 43(2), 459–464. https://doi.org/10.1002/1097-0142(197902)43:2<459::AID-CNCR2820430209>3.0.CO;2-R
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
